Sequenta Receives $13,000,000 Series B Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b32a76f5-c068-4778-b05f-4012a8be3f03&Preview=1
Date
12/8/2010
Company Name
Sequenta
Mailing Address
409 Illinois St. San Francisco, CA 94158
Company Description
Sequenta is a venture funded biotech company dedicated to the discovery and development of clinical diagnostics based on a revolutionary new platform for understanding immune system status.
Website
http://www.sequentainc.com
Transaction Type
Venture Equity
Transaction Amount
$13,000,000
Transaction Round
Series B
Proceeds Purposes
The new funds will be used to continue development and commercialization of molecular diagnostic assays based on a proprietary sequencing approach to the profiling T and B cell receptor repertoires.
M&A Terms
Venture Investor
Index Ventures
Venture Investor
Mohr Davidow Ventures
Venture Investor
Undisclosed